Axon Enterprise, Inc.
AXON News Today: Stay Updated with the Latest Axon Enterprise, Inc. News in Real Time
Find AXON news now at Meyka AI. Stay informed with the latest Axon Enterprise, Inc. stocks updates, including price news, market analysis, and expert insights.
MMEN.CN MedMen Enterprises Inc. CNQ +33.33% on 24 Feb 2026: key outlook and target
MMEN.CN stock jumps 33.33% to C$0.02 on 24 Feb 2026; short-term outlook and model targets included
Volume spike lifts I-PEX (6640.T) to JPY 2,938.00 on JPX 24 Feb 2026: Analyst outlook
Volume spike at I-PEX (6640.T stock) to JPY 2,938.00 on JPX; analysis, Meyka grade and forecast
CUB.TO down 25% pre-market TSX 24 Feb 2026: CubicFarm Systems outlook
Pre-market: CUB.TO stock falls 25% to C$0.015 on TSX 24 Feb 2026. Financials, Meyka AI grade and forecast included
RGS.AX stock Regeneus Ltd (ASX) up 33.33% at close 24 Feb 2026: volume spike
RGS.AX stock jumped 33.33% to A$0.012 on heavy volume at close 24 Feb 2026, signalling renewed investor interest
ECOX $0.0004 (Eco Innovation Group, PNK) 24 Feb 2026: High volume marks most active trading
ECOX stock trades at $0.0004 on heavy volume; analysis, Meyka grade and forecast for ECOX stock
Amazon Shares, NASDAQ AMZN, Drop Following 12B Louisiana Data Center Investment
Amazon shares fell in early trading after the company confirmed a 12 billion dollar investment in Louisiana data centers to expand its artificial intelligence and cloud infrastructure. The stock, listed on the NASDAQ under AMZN, saw short term pressure as investors weighed rising capital spending against long term AI growth. Amazon announced that it will…
4894.T stock down 33.97% to JPY 7,230.00 at JPX close 24 Feb 2026: key risk signals
4894.T stock fell 33.97% to JPY 7,230.00 on JPX close 24 Feb 2026; high volume and valuation gaps increase short-term risk
Gigaset (GGS.F) at €0.018 on XETRA: earnings due 25 Feb could move the price
Intraday: GGS.F stock at €0.018 on XETRA ahead of 25 Feb earnings; metrics, Meyka forecast and risks
Cowen Maintains Buy on Axsome Therapeutics (AXSM) Feb 2026
AXSM analyst rating: Cowen maintains Buy and raises price target to $215; implications for investors and market context